Conmed Corp (NYSE:CNMD)
| 81.04 Delayed Data As of Oct 27 |  -1.85 / -2.23%Today’s Change | 37.66 Today|||52-Week Range 116.81 | -27.53% Year-to-Date |
Latest CNMD News | Press Releases
| Analysts Estimate Conmed (CNMD) to Report a Decline in Earnings: What to Look Out for Oct 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 82.89 |
| Today’s open | 82.66 |
| Day’s range | 80.56 - 83.30 |
| Volume | 294,388 |
| Average volume (3 months) | 269,170 |
| Market cap | $2.4B |
Data as of 4:00pm ET, 10/27/2020
Growth & Valuation
| Earnings growth (last year) | -30.46% |
| Earnings growth (this year) | -43.24% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +10.30% |
| P/E ratio | NM |
| Price/Sales | 3.48 |
| Price/Book | 3.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SWAVShockwave Medical In... | -0.05 | -0.07% |
| GKOSGlaukos Corp | +1.81 | +3.13% |
| CMDCantel Medical Corp | -2.81 | -5.55% |
| NUVANuVasive Inc | -1.32 | -2.59% |
Data as of 4:59pm ET, 10/27/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | $0.23 |
| Annual revenue (last year) | $947.1M |
| Annual profit (last year) | $28.6M |
| Net profit margin | 3.02% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Utica, New York |
Forecasts
